{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T04:30:39Z","timestamp":1788582639676,"version":"build-2803163510"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Rare diseases often present with a variety of clinical symptoms and therefore are challenging to diagnose. Fabry disease is an x-linked rare metabolic disorder. The severity of symptoms is usually different in men and women. Since therapeutic options for Fabry disease exist, early diagnosis is important. An artificial intelligence (AI)-based diagnosis support algorithm for rare diseases has been developed in preliminary studies.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective<\/jats:title>\n<jats:p>Our aim was to extend and train the questionnaire-based AI, capable of distinguishing patients with from those without rare diseases, to achieve satisfactory sensitivity for the detection of a single rare disease, Fabry disease, taking into account gender differences in disease perception.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>We collected 33 complete datasets from patients with confirmed Fabry disease. These records contained answered AI questionnaires, general information on disease progression, demographic information and quality of life (QoL) measures. The AI was trained to distinguish patients with Fabry disease from patients with relevant differential diagnoses. Its performance was assayed using stratified eleven-fold cross-validation and ROC curve calculation. Variables influencing the performance of the AI were examined with linear regression and calculation of the coefficient of determination.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Result<\/jats:title>\n<jats:p>We were able to show that a relatively small sample is sufficient to achieve a sensitivity of 88.12% for the presence of Fabry disease, taking into account gender-specific differences in the disease perception during the pre-diagnostic phase. No confounders of the tool\u2019s performance could be found in the data collected concerning the patients\u2019 quality of life and diagnostic history.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>This study illustrates on the example of Fabry disease that differences between female and male Fabry patients, not only in the expression of symptoms, but also with regard to disease perception, might be relevant influencing variables for improving the performance of AI-based diagnostic support tools for rare diseases.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0326372","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T17:28:26Z","timestamp":1751304506000},"page":"e0326372","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Improving a data mining based diagnostic support tool for rare diseases on the example of M. Fabry: Gender differences need to be taken into account"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-4354-6475","authenticated-orcid":true,"given":"Philipp","family":"Hahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Lechner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer-Georg","family":"Siefen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Lampe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Nordbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenz","family":"Grigull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"L\u00fccke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,6,30]]},"reference":[{"key":"pone.0326372.ref001","author":"K Lauterbach","year":"2022"},{"issue":"1","key":"pone.0326372.ref002","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41572-018-0025-4","article-title":"Lysosomal storage diseases","volume":"4","author":"FM Platt","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"pone.0326372.ref003","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/cge.14102","article-title":"Challenging the traditional approach for interpreting genetic variants: Lessons from Fabry disease","volume":"101","author":"DP Germain","year":"2022","journal-title":"Clin Genet"},{"key":"pone.0326372.ref004","author":"DP Germain","year":"2022"},{"key":"pone.0326372.ref005","author":"TP Mechtler","year":"2011"},{"key":"pone.0326372.ref006","unstructured":"Europ\u00e4isches Parlament und Rat der Europ\u00e4ischen Union. Verordnung (EG) Nr. 141\/2000 des Europ\u00e4ischen Parlaments und des Rates vom 16. Dezember 1999 \u00fcber Arzneimittel f\u00fcr seltene Leiden. Amtsblatt Nr L 018 vom 22\/01\/2000 S 0001 - 0005. 2000;6."},{"issue":"4","key":"pone.0326372.ref007","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s41969-020-00123-8","article-title":"Morbus Fabry","volume":"13","author":"S Baumgartner-Parzer","year":"2020","journal-title":"J Klin Endokrinol Stoffw"},{"key":"pone.0326372.ref008","unstructured":"Blohm E. Lebensqualita\u0308t bei Fabry-Patienten: Erhebung mit dem SF-36 Fragebogen. Inaugural \u2013 Dissertation zur Erlangung der Doktorwu\u0308rde der Medizinischen Fakulta\u0308t der Julius-Maximilians-Universita\u0308t Wu\u0308rzburg. 2012."},{"key":"pone.0326372.ref009","author":"N \u00dc\u00e7eyler","year":"2023"},{"issue":"26","key":"pone.0326372.ref010","first-page":"440","article-title":"Fabry disease-often seen, rarely diagnosed","volume":"106","author":"B Hoffmann","year":"2009","journal-title":"Dtsch Arztebl Int"},{"issue":"6","key":"pone.0326372.ref011","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/AJP.0b013e318074c986","article-title":"Nature and prevalence of pain in Fabry disease and its response to enzyme replacement therapy--a retrospective analysis from the Fabry Outcome Survey","volume":"23","author":"B Hoffmann","year":"2007","journal-title":"Clin J Pain"},{"issue":"11","key":"pone.0326372.ref012","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1136\/jnnp.2008.143693","article-title":"Central nervous system involvement in Anderson-Fabry disease: a clinical and MRI retrospective study","volume":"79","author":"S Buechner","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"pone.0326372.ref013","volume-title":"Sex and Gender Aspects in Clinical Medicine","author":"S Oertelt-Prigione","year":"2011"},{"key":"pone.0326372.ref014","author":"European public health alliance","year":"2022"},{"issue":"1","key":"pone.0326372.ref015","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/bja\/aet127","article-title":"Sex differences in pain: a brief review of clinical and experimental findings","volume":"111","author":"EJ Bartley","year":"2013","journal-title":"Br J Anaesth"},{"key":"pone.0326372.ref016","article-title":"Gendermedizin: Frauen erkranken anders","volume":"117","author":"E Richter-Kuhlmann","year":"2020","journal-title":"Dtsch Arztebl Int"},{"issue":"3","key":"pone.0326372.ref017","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ymgme.2018.06.004","article-title":"European expert consensus statement on therapeutic goals in Fabry disease","volume":"124","author":"C Wanner","year":"2018","journal-title":"Mol Genet Metab"},{"issue":"11","key":"pone.0326372.ref018","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/GIM.0b013e3181f13a4a","article-title":"Agalsidase beta treatment is associated with improved quality of life in patients with Fabry disease: findings from the Fabry Registry","volume":"12","author":"T Watt","year":"2010","journal-title":"Genet Med"},{"key":"pone.0326372.ref019","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1750-1172-5-30","article-title":"Fabry disease","volume":"5","author":"DP Germain","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"pone.0326372.ref020","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.2147\/DDDT.S313789","article-title":"Prompt Agalsidase Alfa Therapy Initiation is Associated with Improved Renal and Cardiovascular Outcomes in a Fabry Outcome Survey Analysis","volume":"15","author":"D Hughes","year":"2021","journal-title":"Drug Des Devel Ther"},{"issue":"5","key":"pone.0326372.ref021","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/jimd.12228","article-title":"Developments in the treatment of Fabry disease","volume":"43","author":"SJ van der Veen","year":"2020","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"pone.0326372.ref022","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/s41467-021-21371-5","article-title":"Lentivirus-mediated gene therapy for Fabry disease","volume":"12","author":"A Khan","year":"2021","journal-title":"Nat Commun"},{"key":"pone.0326372.ref023","first-page":"138","article-title":"Venglustat, an orally administered glucosylceramide synthase inhibitor: Assessment over 3 years in adult males with classic Fabry disease in an open-label phase 2 study and its extension study","author":"PB Deegan","year":"2023","journal-title":"Mol Genet Metab"},{"issue":"1","key":"pone.0326372.ref024","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3390\/ijms22010206","article-title":"Fabry Disease Therapy: State-of-the-Art and Current Challenges","volume":"22","author":"O Azevedo","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"2","key":"pone.0326372.ref025","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ymgme.2015.10.007","article-title":"The management and treatment of children with Fabry disease: A United States-based perspective","volume":"117","author":"RJ Hopkin","year":"2016","journal-title":"Mol Genet Metab"},{"issue":"1","key":"pone.0326372.ref026","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13023-022-02215-x","article-title":"Expert opinion on the recognition, diagnosis and management of children and adults with Fabry disease: a multidisciplinary Turkey perspective","volume":"17","author":"F Ezgu","year":"2022","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"pone.0326372.ref027","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ymgme.2018.02.014","article-title":"Fabry disease revisited: Management and treatment recommendations for adult patients","volume":"123","author":"A Ortiz","year":"2018","journal-title":"Mol Genet Metab"},{"key":"pone.0326372.ref028","author":"A Spatharou","year":"2020"},{"issue":"2","key":"pone.0326372.ref029","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4300\/JGME-D-11-00180.1","article-title":"Impact of a computer-based diagnostic decision support tool on the differential diagnoses of medicine residents","volume":"4","author":"MJ Feldman","year":"2012","journal-title":"J Grad Med Educ"},{"key":"pone.0326372.ref030","first-page":"694","volume-title":"Artificial intelligence in image evaluation and diagnosis: What is the benefit for pediatric radiology? Monatsschrift fur Kinderheilkunde","author":"HJ Mentzel","year":"2021"},{"issue":"4","key":"pone.0326372.ref031","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.gie.2020.06.040","article-title":"History of artificial intelligence in medicine","volume":"92","author":"V Kaul","year":"2020","journal-title":"Gastrointest Endosc"},{"issue":"3","key":"pone.0326372.ref032","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3390\/biomedicines11030887","article-title":"The Impact of Artificial Intelligence in the Odyssey of Rare Diseases","volume":"11","author":"A Visibelli","year":"2023","journal-title":"Biomedicines"},{"issue":"1","key":"pone.0326372.ref033","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13023-020-01424-6","article-title":"The use of machine learning in rare diseases: a scoping review","volume":"15","author":"J Schaefer","year":"2020","journal-title":"Orphanet J Rare Dis"},{"issue":"8","key":"pone.0326372.ref034","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1007\/s10620-006-9202-5","article-title":"Applying data mining techniques in the development of a diagnostics questionnaire for GERD","volume":"52","author":"N Horowitz","year":"2007","journal-title":"Dig Dis Sci"},{"key":"pone.0326372.ref035","unstructured":"M\u00fccke U. Entwicklung und Untersuchung der Einsatzf\u00e4higkeit fragebogenbasierter Data Mining Verfahren in der Diagnostik ausgesuchter Immundefekte im Kindesalter. Dissertation zur Erlangung des Doktorgrades der Medizin in der Medizinischen Hochschule Hannover. 2016; S.20."},{"key":"pone.0326372.ref036","author":"AL Sieg","year":"2018"},{"issue":"120","key":"pone.0326372.ref037","doi-asserted-by":"crossref","first-page":"20160266","DOI":"10.1098\/rsif.2016.0266","article-title":"The power of data mining in diagnosis of childhood pneumonia","volume":"13","author":"E Naydenova","year":"2016","journal-title":"J R Soc Interface"},{"issue":"8","key":"pone.0326372.ref038","article-title":"Diagnostic Support for Selected Paediatric Pulmonary Diseases Using Answer-Pattern Recognition in Questionnaires Based on Combined Data Mining Applications--A Monocentric Observational Pilot Study","volume":"10","author":"A-K Rother","year":"2015","journal-title":"PLoS One"},{"issue":"10","key":"pone.0326372.ref039","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0222637","article-title":"Common pre-diagnostic features in individuals with different rare diseases represent a key for diagnostic support with computerized pattern recognition?","volume":"14","author":"L Grigull","year":"2019","journal-title":"PLoS One"},{"issue":"2","key":"pone.0326372.ref040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172532","article-title":"Diagnostic needs for rare diseases and shared prediagnostic phenomena: Results of a German-wide expert Delphi survey","volume":"12","author":"S Bl\u00f6\u00df","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"pone.0326372.ref041","first-page":"56","article-title":"Health-related quality of life in Norwegian adults with Fabry disease: Disease severity, pain, fatigue and psychological distress","volume":"62","author":"HK Pihlstr\u00f8m","year":"2021","journal-title":"JIMD Rep"},{"issue":"2","key":"pone.0326372.ref042","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ymgme.2007.09.013","article-title":"Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry","volume":"93","author":"WR Wilcox","year":"2008","journal-title":"Mol Genet Metab"},{"issue":"1","key":"pone.0326372.ref043","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/GIM.0b013e31802d8321","article-title":"Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life","volume":"9","author":"RY Wang","year":"2007","journal-title":"Genet Med"},{"key":"pone.0326372.ref044","author":"V Pflieger","year":"2014"},{"key":"pone.0326372.ref045","volume-title":"A Study of Cross-Validation and Bootstrap for Accuracy Estimation and Model Selection. International Joint Conference on Articial Intelligence (IJCAI)","author":"R Kohavi","year":"1995"},{"key":"pone.0326372.ref046","author":"T Fawcett","year":"2007"},{"key":"pone.0326372.ref047","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-015-0296-8","article-title":"Quality of life in patients with Fabry disease: a systematic review of the literature","volume":"10","author":"M Arends","year":"2015","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"pone.0326372.ref048","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s11325-010-0384-x","article-title":"A prediction model based on an artificial intelligence system for moderate to severe obstructive sleep apnea","volume":"15","author":"LM Sun","year":"2011","journal-title":"Sleep Breath"},{"issue":"3","key":"pone.0326372.ref049","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s10772-021-09837-9","article-title":"A hybrid system for Parkinson\u2019s disease diagnosis using machine learning techniques","volume":"25","author":"R Lamba","year":"2022","journal-title":"Int J Speech Technol"},{"issue":"11","key":"pone.0326372.ref050","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1007\/s00415-012-6619-y","article-title":"FabryScan: a screening tool for early detection of Fabry disease","volume":"259","author":"K Arning","year":"2012","journal-title":"J Neurol"},{"issue":"1","key":"pone.0326372.ref051","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/ijcp.12914","article-title":"Time delays in the diagnosis and treatment of Fabry disease","volume":"71","author":"R Reisin","year":"2017","journal-title":"Int J Clin Pract"},{"key":"pone.0326372.ref052","unstructured":"Spatharou A, Hieronimus S, Jenkins J. Transforming healthcare with AI. 2020."},{"key":"pone.0326372.ref053","unstructured":"Smuha N. Policy and Intestment Recommendations for Trustworthy AI: High Level Expert Group on Artificial Intelligence. 2019."}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0326372","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T17:28:41Z","timestamp":1751304521000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0326372"}},"subtitle":[],"editor":[{"given":"Naveen","family":"Joseph,","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,6,30]]},"references-count":53,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0326372","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,30]]}}}